Literature DB >> 16480754

Variants of the paramyxovirus Simian virus 5 with accelerated or delayed viral gene expression activate proinflammatory cytokine synthesis.

Virginia A Young1, Patrick J Dillon, Griffith D Parks.   

Abstract

Our previous results have shown that the parainfluenza virus SV5 is a poor inducer of proinflammatory cytokines interleukin-8 (IL-8) and macrophage chemoattractant protein 1 (MCP-1). By contrast, an engineered P/V mutant rSV5-P/V-CPI- and a naturally-occurring variant WF-PIV (Wake Forest-Parainfluenza Virus) are both potent activators of IL-8 and MCP-1. In the present study, we addressed the question of why rSV5-WT is such a poor inducer of host cytokine responses relative to the two SV5 variants, and we used the CC chemokine RANTES as a measure of host responses. Time course experiments showed high-level secretion of IL-6 and RANTES following infections of human A549 lung epithelial cells with the P/V-CPI- mutant and WF-PIV. By contrast, SV5-WT induced very low cytokine responses, with the notable exception of moderate induction of RANTES. The mechanism of RANTES induction by the two SV5 variants shared common properties, since RANTES secretion from infected cells had similar kinetics, depended on virus replication, correlated with increased RANTES mRNA levels and promoter activation, and was reduced by inhibitors of the p38 MAPK, ERK, and PI3K pathways. Despite the similar mechanisms of RANTES induction, the two SV5 variants differed dramatically in their growth and gene expression kinetics. By comparison to the P/V mutant rSV5-P/V-CPI- which has accelerated viral gene expression, WF-PIV infection showed a prolonged delay in viral replication, and infected cells did not show high-level viral RNA and protein expression until approximately 12-24 hpi. Sequence analysis revealed that the N, P, V, and M genes from WF-PIV differed by 3, 8, 5, and 10 amino acids compared to rSV5-WT, respectively. Chimeric viruses harboring the WF-PIV P/V or M genes in the context of the other rSV5 genes had growth properties similar to rSV5-WT but had a RANTES-inducing phenotype similar to that of the bone fide WF-PIV virus. Our data indicate a role for both the P/V and the M gene products as determinants of RANTES induction in response to SV5 infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480754     DOI: 10.1016/j.virol.2006.01.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Replication-independent activation of human plasmacytoid dendritic cells by the paramyxovirus SV5 Requires TLR7 and autophagy pathways.

Authors:  Mary J Manuse; Caitlin M Briggs; Griffith D Parks
Journal:  Virology       Date:  2010-07-06       Impact factor: 3.616

2.  The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction.

Authors:  Phuong Tieu Schmitt; Greeshma Ray; Anthony P Schmitt
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

3.  Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus.

Authors:  Kritika Kedarinath; Griffith D Parks
Journal:  Pathogens       Date:  2022-04-21

4.  TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  Virology       Date:  2009-11-30       Impact factor: 3.616

5.  TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways.

Authors:  Subhashini Arimilli; John B Johnson; Martha A Alexander-Miller; Griffith D Parks
Journal:  Virology       Date:  2007-04-24       Impact factor: 3.616

6.  Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation.

Authors:  Maria D Gainey; Patrick J Dillon; Kimberly M Clark; Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

7.  Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses.

Authors:  Patrick J Dillon; Griffith D Parks
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

8.  Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

9.  Inhibition of interleukin-6 expression by the V protein of parainfluenza virus 5.

Authors:  Yuan Lin; Minghao Sun; Sandra M Fuentes; Celia D Keim; Terri Rothermel; Biao He
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616

10.  Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy.

Authors:  Candace R Fox; Griffith D Parks
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.